These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6390776)

  • 1. Comparison of the hypotensive effects of streptokinase-(human) plasmin activator complex and BRL 26921 (p-anisoylated streptokinase-plasminogen activator complex) in the dog after high dose, bolus administration.
    Green J; Dupe RJ; Smith RA; Harris GS; English PD
    Thromb Res; 1984 Oct; 36(1):29-36. PubMed ID: 6390776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.
    Ferres H
    Drugs; 1987; 33 Suppl 3():33-50. PubMed ID: 3315613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct].
    Doenecke P; Schwerdt H; Hellstern P; Wenzel E; Bette L
    Klin Wochenschr; 1986 Aug; 64(15):682-7. PubMed ID: 3531704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptokinase and anisoylated streptokinase plasminogen complex. Their action on haemostasis in human volunteers.
    Staniforth DH; Smith RA; Hibbs M
    Eur J Clin Pharmacol; 1983; 24(6):751-6. PubMed ID: 6350023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation].
    Bashkov GV; Aĭsina RB; Kazanskaia NF; Makarov VA; Sirotenko AV; Popova GIu; Zhitkova IuV
    Farmakol Toksikol; 1991; 54(2):46-50. PubMed ID: 1884796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction.
    Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW; Norry EC
    Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
    Jackson CV; Frank JD; Craft TJ; Sundboom JL; Smith GF
    J Pharmacol Exp Ther; 1992 Jan; 260(1):64-70. PubMed ID: 1731052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1984 Apr; 51(2):248-53. PubMed ID: 6234676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acylated derivatives of streptokinase-plasminogen activator complex as thrombolytic agents in a dog model of aged venous thrombosis.
    Dupe RJ; Green J; Smith RA
    Thromb Haemost; 1985 Feb; 53(1):56-9. PubMed ID: 3887635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose systemic streptokinase and acylated streptokinase-plasminogen complex (BRL 26921) in acute myocardial infarction: alterations of the fibrinolytic system and clearance of fibrinolytic activity.
    Köhler M; Hellstern P; Doenecke P; Schwerdt H; Ozbek C; Miyashita C; Winter R; von Blohn G; Bette L; Wenzel E
    Haemostasis; 1987; 17(1-2):32-9. PubMed ID: 3297942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921).
    Matsuo O; Collen D; Verstraete M
    Thromb Res; 1981 Nov; 24(4):347-58. PubMed ID: 7038976
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effects of the acylated streptokinase-plasminogen activator complex BRL 33 575 incubated with normal human plasma.
    Lämmle B; Noll G; Tran TH; Lohri A; Duckert F
    Thromb Haemost; 1984 Jul; 51(3):403-5. PubMed ID: 6548585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction.
    Col JJ; Col-De Beys CM; Renkin JP; Lavenne-Pardonge EM; Bachy JL; Moriau MH
    Am J Cardiol; 1989 May; 63(17):1185-92. PubMed ID: 2653017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Munger MA; Forrence EA
    Clin Pharm; 1990 Jul; 9(7):530-40. PubMed ID: 2198125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Streptokinase and Staphylokinase: Differences in the Kinetics and Mechanism of Their Interaction with Plasminogen, Inhibitors and Fibrin].
    Aisina RB; Mukhametova LI; Gulin DA; Gershkovich KB; Varfolomeyev SD
    Bioorg Khim; 2015; 41(5):565-78. PubMed ID: 26762094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.